IAM

NASD Iambic Therapeutics, Inc.
Oct 16, 2026 · 5:04 PM ET LAST TRADE Market Closed

$23.36 ↓ -0.45 (-1.89%) Trading Down from the previous close of $23.81, $1.64 below the day’s high of $25.00

YTD change
+23.53%
vs 20-day SMA
N/A
vs 200-day SMA
N/A

Price ranges

Previous day
$16.15 $19.70
open $16.15 close $18.91
+$2.76 (+17.09%)
Today
$19.31 $25.00
open $19.31 now $23.36
+$4.05 (+20.97%)
Past week
$0.00 $18.91
from $18.91 now $23.36
+$4.45 (+23.53%)
Past month
$0.00 $18.91
from $18.91 now $23.36
+$4.45 (+23.53%)
This year
$16.15 $25.00
from $18.91 now $23.36
+$4.45 (+23.53%)

Price & Performance

+0.00 (+0.00%) / 6M

No chart data available

Signals & Sentiment

Momentum, market sentiment, and recent alerts

N/A
  • The stock is 18.6% away from all-time highs of $19.70
  • IAM is up 24% since the beginning of the year
  • IAM is up 24% over the past 12 months
  • IAM is up 24% over the past 1 month

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $1.1B

Balance sheet & scale

IncomeN/A
Revenue$9.4M
Cash$180.5M
Debt$5.7K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Market cap $1.1B

Iambic Therapeutics, Inc. develops AI driven platform for drug discovery. It combines proprietary AI-driven platforms with the expertise of experienced drug discovery scientists to identify, design, and optimize novel therapeutic candidates across a range of disease areas. The company was founded 2019 and is headquartered in San Diego, CA.

Competitor comparison

No peer group available for this symbol.

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.